Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GlobalData
Biotech
Biopharma VC dropped 20% in Q1 compared to ’24: GlobalData
Biopharma venture funding dropped 20% in the first quarter of 2025 compared to the same period the year before, according to GlobalData.
Gabrielle Masson
Apr 30, 2025 12:33pm
Midstage cancer tests 'heavily impacted' by COVID-19 disruptions
Jun 9, 2021 7:05am
Trials ramping back up, but slow takeup of places remains
May 12, 2021 7:35am
More trials to get back on track in U.S./U.K. amid vax uptake
Mar 29, 2021 9:37am
Make rare disease trials virtual to boost uptake: report
Mar 11, 2021 3:29am
New COVID-19 mutations putting a strain on trial resumptions
Feb 16, 2021 7:25am
